Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Brüggemann BR et al. - The chronic and severely ill patients in our sample represent a high-risk population for whom a polypharmacy of psychotropic substances might be advisable. When polypharmacy becomes necessary, it should only be administered according to evidence-based data. Due to the widespread use of polypharmacy in psychiatric care units, we are in urgent need of controlled studies further investigating combinations of substances


Previous Article Next Article

Today in Neuro/Psych pharmacology...keeping you current

Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy
CNS Drugs, 06/15/09

Use of antipsychotics in neuropsychiatric symptoms of dementia
Geriatrics, 05/18/09

Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHD
Pediatrics, 07/02/09

Today in Pharmacy Management...keeping you current

Community pharmacist-initiated screening program for osteoporosis: Randomized controlled trial
Osteoporosis International, 06/10/09

Pharmacological Management of Psychosis in Elderly Patients with Parkinsonism
American Journal of Medicine, 06/25/09

Trends and determinants of prescription medication use for treatment of osteoporosis
American Journal of Health-System Pharmacy, 06/18/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address